Latest filing published 19 Dec 2025 for Avidity Biosciences, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Charles Calderaro III in Avidity Biosciences, Inc. We count 4 filings; the first trade dates from 6 January 2025 and the latest from 27 February 2026.
On the market, this insider has only sold: 1 sale, €230k in total. The rest of the record consists of 2 share grants. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 27 February 2026, reports a transaction in Avidity Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations